Novartis is planning to develop a new flagship manufacturing hub in North Carolina as part of a $23 billion investment by the Switzerland-based pharmaceutical giant to significantly expand its operations in the United States.

Novartis is planning to develop a new flagship manufacturing hub in North Carolina as part of a $23 billion investment by the Switzerland-based pharmaceutical giant to significantly expand its operations in the United States.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
2000 Science Dr, Morrisville, NC
2500 Tricenter Blvd, Durham, NC
Manufacturing